Comparison of clinical characteristics, depression questionnaire results and midbrain SERT binding affinity on 123I-ADAM between groups of patients with symptoms of depression (BDI and EST-Q score > 11 points) and without symptoms of depression. This evidence concerns the gene SLC6A4 and depressive symptom measurement.